Status:
RECRUITING
Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this randomized clinical trial is to evaluate the impact of an expert opinion during the management of patients with severe bleeding on oral anticoagulants. The main question it aims to an...
Eligibility Criteria
Inclusion
- Major patient treated with oral anticoagulants, admitted in an emergency department
- For suspected major bleeding defined according to the criteria of the International Society of Thrombosis and Haemostasis
- Able to give informed consent to participate in research or, in the event of an emergency, to take charge of a reference person
- Affiliated to a Social Security scheme.
Exclusion
- Pregnant or breastfeeding women
- Patient under guardianship, curatorship or safeguard of justice
- Administration within the last 24 hours of parenteral anticoagulant.
- Refusal to participate
Key Trial Info
Start Date :
October 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05928091
Start Date
October 16 2023
End Date
December 31 2027
Last Update
December 8 2025
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Aurillac
Aurillac, France, 15000
2
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000
3
CHU Grenoble
Grenoble, France, 38000
4
CH Le Puy
Le Puy-en-Velay, France, 43000